Moonjoo Han1, Julie C Fitzgerald, Fran Balamuth, Luke Keele, Elizabeth R Alpern, Jane Lavelle, Marianne Chilutti, Robert W Grundmeier, Vinay M Nadkarni, Neal J Thomas, Scott L Weiss. 1. *Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania †Division of Emergency Medicine, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania ‡McCourt School of Public Policy and Department of Government, Georgetown University, Washington DC §Division of Emergency Medicine, Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois ||Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania ¶Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania #Division of Pediatric Critical Care Medicine, Penn State Hershey Children's Hospital, Penn State University College of Medicine, Hershey, Pennsylvania.
Abstract
OBJECTIVE: Delayed antimicrobial therapy in sepsis is associated with increased hospital mortality, but the impact of antimicrobial timing on long-term outcomes is unknown. We tested the hypothesis that hourly delays to antimicrobial therapy are associated with 1-year mortality in pediatric severe sepsis. DESIGN: Retrospective observational study. SETTING: Quaternary academic pediatric intensive care unit (PICU) from February 1, 2012 to June 30, 2013. PATIENTS: One hundred sixty patients aged ≤21 years treated for severe sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We tested the association of hourly delays from sepsis recognition to antimicrobial administration with 1-year mortality using multivariable Cox and logistic regression. Overall 1-year mortality was 24% (39 patients), of whom 46% died after index PICU discharge. Median time from sepsis recognition to antimicrobial therapy was 137 min (IQR 65-287). After adjusting for severity of illness and comorbid conditions, hourly delays up to 3 h were not associated with 1-year mortality. However, increased 1-year mortality was evident in patients who received antimicrobials ≤1 h (aOR 3.8, 95% CI 1.2, 11.7) or >3 h (aOR 3.5, 95% CI 1.3, 9.8) compared with patients who received antimicrobials within 1 to 3 h from sepsis recognition. For the subset of patients who survived index PICU admission, antimicrobial therapy ≤1 h was also associated with increased 1-year mortality (aOR 5.5, 95% CI 1.1, 27.4), while antimicrobial therapy >3 h was not associated with 1-year mortality (aOR 2.2, 95% CI 0.5, 11.0). CONCLUSIONS: Hourly delays to antimicrobial therapy, up to 3 h, were not associated with 1-year mortality in pediatric severe sepsis in this study. The finding that antimicrobial therapy ≤1 h from sepsis recognition was associated with increased 1-year mortality should be regarded as hypothesis-generating for future studies.
OBJECTIVE: Delayed antimicrobial therapy in sepsis is associated with increased hospital mortality, but the impact of antimicrobial timing on long-term outcomes is unknown. We tested the hypothesis that hourly delays to antimicrobial therapy are associated with 1-year mortality in pediatric severe sepsis. DESIGN: Retrospective observational study. SETTING: Quaternary academic pediatric intensive care unit (PICU) from February 1, 2012 to June 30, 2013. PATIENTS: One hundred sixty patients aged ≤21 years treated for severe sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We tested the association of hourly delays from sepsis recognition to antimicrobial administration with 1-year mortality using multivariable Cox and logistic regression. Overall 1-year mortality was 24% (39 patients), of whom 46% died after index PICU discharge. Median time from sepsis recognition to antimicrobial therapy was 137 min (IQR 65-287). After adjusting for severity of illness and comorbid conditions, hourly delays up to 3 h were not associated with 1-year mortality. However, increased 1-year mortality was evident in patients who received antimicrobials ≤1 h (aOR 3.8, 95% CI 1.2, 11.7) or >3 h (aOR 3.5, 95% CI 1.3, 9.8) compared with patients who received antimicrobials within 1 to 3 h from sepsis recognition. For the subset of patients who survived index PICU admission, antimicrobial therapy ≤1 h was also associated with increased 1-year mortality (aOR 5.5, 95% CI 1.1, 27.4), while antimicrobial therapy >3 h was not associated with 1-year mortality (aOR 2.2, 95% CI 0.5, 11.0). CONCLUSIONS: Hourly delays to antimicrobial therapy, up to 3 h, were not associated with 1-year mortality in pediatric severe sepsis in this study. The finding that antimicrobial therapy ≤1 h from sepsis recognition was associated with increased 1-year mortality should be regarded as hypothesis-generating for future studies.
Authors: David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Julie C Fitzgerald; Michelle E Ross; Neal J Thomas; Scott L Weiss; Fran Balamuth; Amanda Hyre Anderson Journal: Pediatr Nephrol Date: 2018-06-14 Impact factor: 3.714
Authors: Ithan D Peltan; Samuel M Brown; Joseph R Bledsoe; Jeffrey Sorensen; Matthew H Samore; Todd L Allen; Catherine L Hough Journal: Chest Date: 2019-02-16 Impact factor: 9.410
Authors: Audrey Marilyn Smith; Hendry R Sawe; Michael A Matthay; Brittany Lee Murray; Teri Reynolds; Teresa Bleakly Kortz Journal: Front Pediatr Date: 2021-11-30 Impact factor: 3.418
Authors: Edmond C K Li; Sela Grays; Abner Tagoola; Clare Komugisha; Annette Mary Nabweteme; J Mark Ansermino; Craig Mitton; Niranjan Kissoon; Asif R Khowaja Journal: PLoS One Date: 2021-11-17 Impact factor: 3.240
Authors: Julie C Fitzgerald; Michelle E Ross; Neal J Thomas; Scott L Weiss; Fran Balamuth; Marianne Chilutti; Robert W Grundmeier; Amanda Hyre Anderson Journal: Pediatr Nephrol Date: 2020-07-25 Impact factor: 3.714